Background: Even though it is well known that patients with chronic kidney disease (CKD) have high tuberculosis (TB) risk, there is limited data that described its burden at the global, regional, and country-level. Thus, this study aimed to assess the pooled incidence of TB in patients with CKD. Method: The PRISMA method was used to perform this systematic review and meta-analysis. Electronic and gray literature sources were investigated for studies published between 2000 and 2021. Studies that reported tuberculosis in CKD patients were included. The JBI checklist was used to assess the study's quality, and STATA version 16 was used for analysis. The I2 heterogeneity test was employed to assess study heterogeneity. To examine publication bias, funnel plots and Egger's regression tests were performed. We conducted trim-and-fill analysis to adjust publication bias. Findings: In total, 104 studies with a total sample size of 1,548,774 were considered in the search. The incidence of tuberculosis in CKD patients ranges from 60/100,000 in the United Kingdom to 19,270/100,000 in China. The pooled TB incidence was estimated as 3718/100,000 (95%CI; 3024, 4411). Higher pooled TB incidence was found among CKD patients residing in the African Region (9952/100,000, 95%CI; 6854, 13,051) followed by South-East Asian (7200/100,000, 95%CI; 4537, 9863) and Eastern Mediterranean (5508/100,000, 95%CI; 3470, 7547) regions. In particular, patients on hemodialysis (5611/100,000, 95%CI; 4186, 7035) and on peritoneal dialysis (3533/100,000, 95%CI; 2220, 4846) had higher incidence compared to post-renal transplantation (2700/100,000, 95%CI; 1878, 3522) and pre-dialysis patients (913/100,000, 95%CI; 407, 1418). Furthermore, extrapulmonary tuberculosis (2227/100,000) was shown to be more common than pulmonary tuberculosis (1786/100,000). Interpretation: This study identifies a higher incidence of TB in patients with CKD with a regional disparities. Thus, the authors recommend active TB screening in this group of individuals. PROSPERO registration number CRD42021297074. Funding: None to declare. Declaration of Interest: We declare no competing interests.